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The current study was designed to evaluate the phytochemical proﬁle and biological properties
(antioxidant, enzyme inhibitory and cytotoxic activity) of methanolic, ethanolic, ethyl-acetate and water
extracts of Alchemilla vulgaris from Southeast Serbia (central Balkan) which was traditionally used to
alleviate and treat many diseases. Bioactive compounds were characterized by LC-MS/MS technique and
biological properties were evaluated using antioxidant, enzyme inhibitory and cytotoxic assays. Twenty-
six phenolic compounds were quantiﬁed in methanolic, ethanolic, ethyl acetate and water extracts,
whereas the highest yields were found in ethyl-acetate (EA) extract (gallic acid, caﬀeic acid, catchin,
quercetin). This extract has also shown the greatest antioxidant, anticancer and inhibitory enzyme
activities which were demonstrated for the ﬁrst time in this study. The obtained results indicated that
Alchemilla vulgaris from South Serbia possesses high potential for pharmaceutical applications.Introduction
Nature has been an inexhaustible source of bioactive
compounds which have been used since ancient times for
treatment of many diseases. Today more interest is being paid
to understanding the complex role of plant nutrition where
medical plants have particular importance. These plants
include various types of plants for medicinal purposes. They are
considered as a rich source of bioactive ingredients. Serbia is
one of the world's most biodiverse centers, rich in medical
plants, where some of them have not been determinated yet or
there is no information on their ingredients and bioactivity.13
Alchemilla vulgaris, an aggregate species, commonly known
as Lady's mantle or lion's foot, is a perennial herbaceous plant
belonging to the rose family (Rosaceae).
The status of the species Alchemilla vulgaris is still not
completely resolved and there are a few opinions. However,
most of them treat the taxon as an aggregate of microspecies,
which were also considered as subspecies or varieties of the
species.nd Environmental Protection, Faculty of
siteja Obradovi´ca 3, 21000 Novi Sad,
.ac.rs; Fax: +381 21454065; Tel: +381
Biological Research “Siniˇsa Stankovic´”,
cuk University, Konya, Turkey
e, Serbia
3According to Flora of Serbia (Genus Alchemilla, Gajic´, 1972)
name of the species – Alchemilla vulgaris L. is valid; the species
is present in Serbia with three subspecies (subsp. montana,
subsp. pratensis and subsp. vulgaris).15
Among ethnobotanical reports on Alchemilla vulgaris for
Southeast Europe and the territory of Balkan peninsula, it is to
mention a comprehenisve work of Tucakov (1997), and his
reports on adstringent and antidiarrheal, as well as eﬀects
against pruritus vulvae, bleeding from uterus and menstrual
pains. The most used folk names according to Simonovic (1959)
are: “virak”, “vrkuta”, “rosanica”, “biserak”, “virkovina”, “viric´”
and “gospinplasˇt” (it is interesting that the latter literally means
Lady's mantle).12,13
It is 30 to 50 cm long half-rosette herbaceous plant with
corrugated and lobed kidney-shaped to semicircular leaves and
the yellowish-green owers form clusters. The plant blooms
from June through to September and can be found on road-
sides, grasslands bank, and mountain slopes.
Aerial parts of the plant are oen used against gastrointes-
tinal diseases and inammatory processes, as well as for
improvement wound healing due to its strong antimicrobial
and anti-inammatory eﬀects.1 The plant is very popular espe-
cially due to its great eﬀect against women's problems and
diseases such as broids, cysts, endometriosis, infertility, relief
of menstrual problems and regulation of the menstrual cycle
and reproductive and thyroid hormones balancing.2 Extract of
the plant exhibits high scavenge potential, especially towards
superoxide anion radical. The results obtained in some studies
indicate that presence of some phenolics, especially tannins,
may contribute to the antioxidant activity.3,4 Furthermore, TakirThis journal is © The Royal Society of Chemistry 2019
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View Article Onlineet al. (2015) demonstrated that methanolic extract of Alchemilla
vulgaris has shown vasorelaxant and hypotensive eﬀects.5
The extracts of leaves and roots of Alchemilla vulgaris have
been reported to inhibit the orthopox viruses in Vero cell lines.6
Bahadir et al., 2017 have performed in their study that extracts
of Alchemilla vulgaris demonstrated a hepatoprotective activity
increasing the aminotransferase (ALT) level in carbon tetra-
chloride induced mice serum.7
In the Southeast Europe and the Balkan peninsula, the
Lady's mantle is very popular and acknowledged medicinal
plant, which is traditionally used in folk medicine and in range
of herbal remedies. The herb is mostly used for preventing of
woman illnesses, such as menstrual problems, the oligomeno-
rhea and dysmenorrheal, the menopausal complaints, for
regulation of vaginal secretion, polycystic ovaries and even for
infertility.8–10 Moreover, the Lady's mantle is used as diuretic,
anti-anemic and anti-diabetic, for wounds and ulcers, hernias
and muscle atrophy,11 and it is readily used for wound healing,
especially when used externally for ulcers, eczema and skin.
There are also notes on use for mild and nonspecic diarrhea
and for slow metabolism.12 As reported for other regions, the
most records refers to woman illnesses and disorders uses, in
addition to astringent, antihemorrhagic, tonic, cardiotonic and
diuretic eﬀects.11 In general, there are not many reports on
detailed phytochemical prole of Alchemilla and related bio-
logical properties, especially focusing on anticancer properties
and in particular of the estrogen depended cancer lines. The
current study focuses on phytochemical composition assess-
ment, targeting the phenolic compounds, in diﬀerent extracts
of Alchemilla vulgaris collected from the central Balkan (South-
east Serbia) region. The chosen populations originated from
sites where the plant material is collected from the wild for
Serbian and regional market needs. The main goal of the
present study was to verify the existing ethnobotanical data by
performing several antioxidant activity tests, as well as the
anticancer and enzyme activity analyses. Evaluation of antioxi-
dant capacity has been also performed using diﬀerent tests
such as 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,20-azinobis-(3-
ethylbenzothiazoline-6-sulfonic acid (ABTS), Cupric Reducing
Antioxidant Capacity (CUPRAC), phosphomolibdenum, metal
chelating and Ferric Reducing Antioxidant Power (FRAP). Con-
cerning already known health benecial eﬀects of the plant, in
rst uses for gynecological disorders 8, we decided to perform
investigation on anticancer activity of plant extracts on cancer
cells obtained from reproductive tissues, such as human breast
aidenocarcinoma (MCF7 cell line), cervical adenocarcinoma
(HeLa) and ovarian carcinoma (A2780) in addition to prostate
adenocarcinoma (PC-3 cell line). The eﬃcacy of diﬀerent
Alchemilla vulgaris extracts against cancer cell lines was evalu-
ated using two viability tests, MTT based on the measurement
of mitochondrial respiration and crystal violet (CV), on the
number of adherent cells in culture that retained aer the
treatment.
There are also reports which have shown that plants from
Alchemilla genus were traditionally used for skin and neurode-
generative disorders and against diabetes and gastrointestinal
problems of this plant,14–17 its ability to inhibit anti-This journal is © The Royal Society of Chemistry 2019cholinesterase,41 anti-tyrosinase and anti-amylase activity of A.
vulgaris extracts will be investigated in this study.
These investigations were performed to verify whether there
are some other biological performances of Lady's mantle
extracts which have been neglected so far, as there is not such
ethnopharmacological information.
For best of our knowledge, the evaluation of Lady's mantle
anticancer activity, especially on estrogen depended tumors, is
reported for the rst time. Summarily, the phytochemical
characterization in relation to antioxidant activity, enzyme
inhibitory eﬀects and anticancer activity of diﬀerent Alchemilla
vulgaris extracts are presented to clarify already known ethno-
pharmacological records, as well as to identify some novel
possible biological eﬀects of the plant.Material and methods
Plant material
Plant material was collected at the owering stage in
midsummer 2017, from the site situated in south Serbia, the
Vlasina lake (E 22.36446000 N 42.73636300, 1234 m above sea
level). The habitat of the population is wet grassland of the
Calthion type. Plant vouchers were deposited at Herbarium of
Applied Botany Department of the Faculty of Agriculture,
University of Belgrade, under voucher code 85000 BEO. The
collected material was air dried.Extracts preparation
Dry plant material was macerated for 24 h in 80% methanol (v/
v), 70% ethanol (v/v), 70% ethylacetate (v/v) and distilled water
(dH2O) at room temperature using incubator shaker and l-
trated (IKA®). The supernatants were taken for drying. The
obtained residues were dissolved in dimethyl sulfoxide (DMSO)
to the concentration of 10 mg mL1. The extracts (methanolic-
MeOH, ethanolic-EtOH, ethylacetate-EA, water-H2O) were
stored in dark at +4 C until further analyses.Quantication of bioactive compounds using liquid
chromatography tandem-mass spectrometry (LC-MS/MS)
technique
Determination of 45 selected phenolic compounds was per-
formed according to previously described method.18
Data were acquired in dynamic multiple reactionmonitoring
(MRM) mode, using the optimized compound-specic param-
eters. For all the compounds, peak areas were determined using
Agilent Mass Hunter Workstation soware – Qualitative Anal-
ysis (ver. B.03.01.). Calibration curves were plotted and samples'
concentrations calculated using the OriginLabs Origin Pro
(ver. 9.0) soware.Assessment of antioxidant activity and total content of
phenolic compound
DPPH assay. Colorimetric DPPH radical scavenging activity
was measured according to the method described by Espin
et al., 2000.19 The obtained results were expressed as milligramsRSC Adv., 2019, 9, 37474–37483 | 37475
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View Article Onlineof Trolox equivalents per gram of dry weight (mg TE per g d.w.),
calculated according to the Trolox standard calibration curve.
ABTS assay. The ABTS radical scavenging ability was deter-
mined according to the method reported by Re et al. (1999). The
results were evaluated as Trolox equivalents per gram of dry
weight (mg TE per g d.w.).
CUPRAC assay. The cupric reducing power ability was
detected by CUPRAC assays as reported by Apak et al. (2006).60
The results were expressed as Trolox equivalents per gram of dry
weight (mg TE per g extract d.w.).
Phosphomolybdenum assay. The phosphomolybdenum
assay was performed according to the method reported by
Prieto et al. (1999).20 The results were evaluated as Trolox
equivalents per gram of dry weight (mmol TE per g d.w.).
Metal chelating. Ferrozine assay was performed to detect the
metal chelating ability as reported by Dinis et al. (1994).61 The
results were provided as ethylenediaminetetraacetic acid
(EDTA) equivalent (mg EDTAE/g extract).
FRAP assay. The FRAP assay was conducted according to
Benzie and Strain (1996), adapted for 96 well plate. The results
were expressed as mg of ascorbic acid equivalents per g of dry
weight (mg AAE per g d.w.) using the calibration curve of
ascorbic acid.22
Each antioxidant assay was carried out in triplicate and
results were expressed as mean values.
TPC assay. Total phenolic compounds were determined with
Folin-Ciolcateu reagent using the method of Medina-Remon
et al. (2009).23 The results were expressed as milligrams of
gallic acid equivalents per g dry weight (mg GAE per g d.w.)
using standard calibration curve of gallic acid.
Enzyme inhibitory activity
The extracts were tested as sources of several enzyme inhibitors,
including a-amylase, cholinesterases (AChE and BChE), and
tyrosinase. The procedures of these assays were reported in our
earlier work.23–27 The enzyme inhibitor eﬀects were evaluated as
equivalents of acarbose for a-amylase, galantamine for acetyl
cholinesterase (AChE) and butyryl cholinesterase (BChE), and
kojic acid (KAE) for tyrosinase.
Reagents and cells
Culture medium RPMI-1640 and Dulbecco's Modied Eagle
Medium (DMEM) were purchased from Biowest (MO, USA).
Dimethyl sulfoxide (DMSO), phosphate-buﬀered saline (PBS),
fetal calf serum (FCS) were acquired from Sigma (St. Louis, MO,
USA).3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) was bought from AppliChem (MO, USA) while
crystal violet was obtained from Mol (Belgrade, Serbia). The
Penicillin Streptomycin solutionsolution was bought from Bio-
logical Industries (Cromwell, CT, USA). MCF7(breast adeno-
carcinoma), HeLa (cervical adenocarcinoma) and PC-3 prostate
(adenocarcinoma) cell lines were obtained from American Type
Culture Collection (Rockville, MD, USA) while the A2780
(ovarian carcinoma) cells were from European Collection of
Authenticated Cell Cultures (Salisbury, UK). Cell lines MCF7
and PC-3 were routinely cultivated in HEPES-buﬀered RPMI-37476 | RSC Adv., 2019, 9, 37474–374831640 medium while HeLa and A2780 cells were cultivated in
DMEM. Both mediums were supplemented with 10% heat-
inactivated FCS, 2 mM L-glutamine, 0.01% sodium pyruvate,
penicillin (100 units per mL) and streptomycin (100 mg mL1)
and cells were maintained at 37 C in a humidied atmosphere
with 5% CO2. For viability screening MCF7 and HeLa cells were
seeded at 2  103 cells per well, PC-3 cells at 5  103 cells per
well and A2780 in at 3  103 cells per well overnight and then
treated with a wide range of concentration of A. vulgaris extracts
for 72 h. Peritoneal exudates cells were collected from the
peritoneal cavity of C57BL/6 mice by rinsing with ice-cold PBS.
Mice were originated from the facility at the Institute for Bio-
logical Research “Siniˇsa Stankovic´” (IBISS), University of Bel-
grade (Belgrade, Serbia). Cells were washed with PBS, seeded at
1.5  105 cells per well in 96-well plates and allowed to adhere
overnight. Before treatment, non-adherent cells were removed
and cells were then exposed to the same concentration range of
isolated extracts.
Determination of cell viability by mitochondrial
dehydrogenase (MTT) and crystal violet (CV) assays
The activity of mitochondrial dehydrogenase was dened by
a reduction of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) to formazan. Cells were seeded
overnight and treated with experimental compounds for 72
hours. Aerward, cells were cultivated in the presence of 0.5 mg
mL1 MTT (Sigma, St Louis, MO, USA) from 30 min 1 h.
Thereaer, the medium was discarded and cells were lysed in
DMSO. The conversion of MTT to formazan by metabolically
viable cells was measured at 540 nm and cell viability was
calculated as a percentage of control, untreated cells.
For CV test, cells were xed with 4% of paraformaldehyde
(PFA) and stained with 1% CV solution for 15 min at RT.
Aerward, cells were washed and dried. Dye was dissolved in
acetic acid and the absorbance was measured at 540 nm.
Statistical analysis
For data analysis, the Statistica 12 soware was used. To analyze
the signicance of the diﬀerences between applied treatments
the analysis of variance (ANOVA), followed by the Student-
Newman-Keuls test was used. A p value less than 0.05 were
considered signicant.
Results and discussion
LC-MS/MS characterization of phenolic compounds
It is well-known that the avonoids and their glycosides are
responsible for antioxidant, anticancer, and cardioprotective
activity.28 LC-MS/MS analysis was carried out to get insight into
polyphenolic prole of A. vulgaris extracts and results are pre-
sented in the Table 1. The study showed variations in the
amounts of phenolic compounds among the investigated
extracts. The obtained results have shown clearly that EA extract
was the richest in phenolic compounds. On the other hand, the
number of quantied phenols and their amounts was notable
lower than in the water extract. Phenolic acids, mainly the gallicThis journal is © The Royal Society of Chemistry 2019
Table 1 The concentrations of selected phenols in Alchemilla vulgaris extracts obtained by LC-MS/MS
Compoundsa
Quantication (mg g1 dry weight)
MeOH EtOH EA H2O
p-Hydroxybenzoic acid <loq <loq 135.45  0.21 <loq
Protocatechuic acid <loq <loq 255.94  0.36 <loq
2,5-Dihydroxybenzoic acid <loq 74.00  1.52 45.74  0.01 3.35  2.21
p-Coumaric acid 25.68  1.12 23.02  00.33 470.21  0.44 <loq
Gallic acid <loq <loq 2465.79  0.01 <loq
Esculetin <loq <loq 353.03  0.11 <loq
Caﬀeic acid <loq 69.19  1.11 1138.54  0.30 <loq
Quinic acid 284.56  0.17 544.85  0.90 <loq 157.99  0.45
Ferulic acid <loq <loq 346.87  0.12 <loq
Genistein <loq <loq 94.01  0.10 <loq
Apigenin <loq 16.30  0.01 501.97  0.41 <loq
Naringenin <loq <loq 15.40  0.70 <loq
Luteolin 23.15  0.44 50.88  1.08 638.09  0.02 <loq
Kaempferol <loq <loq 364.00  0.22 <loq
Catechin 704.55  0.54 396.16  0.01 8144.98  0.01 <loq
Chrysoeriol <loq 6.714  1.36 222.63  0.99 <loq
Quercetin <loq <loq 4541.70  0.04 <loq
Chlorogenic acid 258.01  1.05 510.43  1.66 23.13  0.11 74.69  0.33
Apigenin-7-O-b-glucoside 40.20  2.11 119.61  0.10 141.6  0.15 6.43  0.01
Luteolin-7-O-b-glucoside 903.94  0.03 1186.34  0.24 329.71  0.04 106.65  1.05
Quercitrin 84.58  1.05 168.56  2.02 70.37  2.15 19.72  0.01
Kaempherol-3-O-glucoside 195.55  0.33 151.52  1.05 1038.52  1.01 30.75  2.30
Quercitrin-hexosides 424.27  0.55 853.40  1.10 2274.85  1.12 86.27  1.45
Rutin 71.06  0.05 64.63  1.17 <loq 32.66  2.05
a Values are means  SD of three measurement; <loq – less than limit of quantiacation.
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View Article Onlineand caﬀeic acids were the most presented and recorded for EA
extract only. Generally, the amount of gallic and caﬀeic acids
was about ten times higher comparing with the other phenolic
acids in all tested extracts. Also, we can notice that chlorogenic
acid was quantied in the highest amount in EtOH extract but
in a lowest amount in EA extract. The health-benets of this
phenol acid is correlated to several health benets including
antioxidant, anticancer, antimutagenic, anti-diabetic eﬀects.29,30
Duckstein et al.31 have detected in Alchemilla vulgaris extracts
a signicant concentration of phenolic acids, such as chloro-
genic, gallic, ellagic acids in lower concentrations.
Besides phenolic acids, the avonoids catechin, and quer-
cetin were recorded in signicant concentration in EA extract,
where catechin was the most dominant (8144.98 mg g1). The
catechin was also determined inMeOH and EtOH extract, but in
a much lower value (704.55 mg g; 396.16 mg g1) than in EA
extract. Quercetin was found in signicant quantity only in the
EA extract (4541.70 mg g1). A plenty of studies supported
various health benets. This phenolic compound is reputable
as one of the most powerful antioxidant,31,32 while several
studies have shown the a strong connection between catechin
and inhibition of cancerogenesis, such like suppression on
breast and ovarian cancer cell growth.33,34 Flavonoid glucosides
were identied in all tested extracts, and generally their
concentration were the most abundant in EA extract. The
highest concentration of luteolin-7-O-b-glucoside was found in
the EtOH (1186.34 mg g1) and MeOH (903.94 mg g1) extractsThis journal is © The Royal Society of Chemistry 2019and apigenin-7-O-b-glucoside was detected in much lower
concentration in all extracts. Further, kaempherol-3-O-gluco-
side and quercitrin-hexosides were noticed in ET extract in
plentiful amount (1038.52 mg g1; 2274.85 mg g1). Due to the
fact that the information related to phenol prole of this plant
is very scattered and that there are no reports for A. vulgaris
from this region (locality), the results obtained in this study
represent a signicant contribution to ethnobotany and
phytomedicine.
Total phenolic content and antioxidant activity
The results presented in Table 2 have shown the means of the
total phenolics content and antioxidant activity of A. vulgaris
extracts using several in vitro assays. The total phenolic content
were strongly correlated with antioxidant activity, whereas the
EA extract showed the highest content of total phenol
compounds (9.65 mg GAE per g) of extract and therefore the
highest antioxidant activity.
Uniformly, it can be concluded that the EA extract demon-
strated the highest antioxidant potential, where the most
pronounced and signicant antioxidant eﬀect of tested extracts
was observed for DPPH and FRAP assays (DPPH: 502.56 mg TE
per g extract; FRAP: 8745.31 mg EAA per g of dry extract), fol-
lowed byMeOH extract. The H2O extract has shown signicantly
low anti-radical activity compared to the other extracts. It is not
unusual for antioxidant assays to be less sensitive and accurate
to some bioactive compounds that are presented in the testesRSC Adv., 2019, 9, 37474–37483 | 37477
Table 2 Evaluation of antioxidant potential and total phenolic contenta
A. vulgaris extracts
MeOH EtOH EA H2O
DPPHc (mg TE per g extract) 153.30  0.013b 95.99  0.005d 502.56  0.01a 89.25  0.02c
ABTSc+ (mg TE per g extract) 143.55  3.65b 119.62  3.20c 174.05  0.90a 37.50  0.39d
CUPRAC (mg TE per g extract) 216.14  6.86c 203.53  9.29b 283.16  12.36a 78.56  0.26d
Phosphomolibdenum (mmol TE per g extract) 1.77  0.01b 1.57  0.02b 2.22  0.07a 0.53  0.03c
Metal chelating (mg EDTAE per g extract) 42.58  0.26a 42.32  0.05a 37.96  1.29b 39.23  0.32b
Reducing power (mg EAA per g of extract) 7899.45  0.49b 6405.75  0.08c 8745.31  0.04a 3240.09  0.08d
Total phenolics content (mg GAE per g of extract) 7.71  0.01b 7.40  0.03b 9.65  0.02a 6.89  0.03b
a Values expressed are means S.D. of three parallel measurements; a–d means in the same row not sharing the same superscript are signicantly
diﬀerent (p < 0.05); TE: trolox equivalent; EDTAE: EDTA equivalent; GAE: gallic acid equivalent.
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View Article Onlinesamples. Therefore, more than two assays should be used in
order to obtain more completed results of antioxidant eﬀect.35
Using DPPH, ABTSc+and cOH assays, Boroja et al., 2018 have
demonstrated a great antioxidant potential of the Lady's mantle
methanol extract which has been higher than synthetic
antioxidant.4Table 4 IC50 values of eﬀect Alchemilla vulgaris extracts in
cytotoxicity
Cell line Assay
IC50 (mg mL
1)
MeOH EtOH EA H2O
A2780 MTT 27.9  1.9 40.3  0.4 43.3  0.9 67  2.4
CV 38.3  1.1 43.9  0.1 42.6  1.3 78.4  1.9
HeLa MTT 80.6  6.3 84.75  5 46.4  5.1 >100
CV >100 >100 53.8  3.9 >100
MCF7 MTT 41.9  0.6 58.7  1.6 31.3  1.5 94.1  1.2
CV 47.2  0.4 64.4  0.1 37.5  5 95  7.1
PC-3 MTT 54.4  2.5 43.5  1.1 18.7  0.9 >100
CV 73.5  4.2 61.1  4.7 31.7  0.3 >100Enzyme inhibitory eﬀects of the A. vulgaris extracts
To determine enzyme inhibitory eﬀects of A. vulgaris extracts,
cholinesterases, tyrosinase and amylase were selected as target
enzymes. The results are presented in Table 3. The highest
AChE inhibition was provided by EA extract (5.21 mg GALAE per
g) and other extracts had almost similar inhibitory eﬀects on the
enzyme. The activity for EA may be linked with the higher level
of phenolics and this approach was supported by several
researchers, who reported the positive correlation between
phenolic level and AChE inhibition.27,36 However, the BChE
inhibition eﬀects can be ranked as H2O > EtOH > EA > MeOH.
The observed BChE inhibitor eﬀect for H2O can be attributed to
non-phenolic inhibitors37 since the water extract, as expected,
exhibited the lowest phenolic level (see Table 2). Regarding
tyrosinase inhibitory eﬀects, the best activity was observed for
MeOH (79.84 mg KAE per g), followed by EtOH, EA and H2O.
These ndings for tyrosinase inhibitory eﬀects might be con-
nected with the of phenolics that are presented in the tested
extracts, including apigenin-7-O-b-glucoside, luteolin-7-O-b-
glucoside, quercetin and rutin, which have been alreadyTable 3 Enzyme inhibitory eﬀects of Alchemilla vulgaris extractsa
Enzyme inhibition assays
A. vulgaris extrac
MeOH
AChE inhibition (mg GALAE per g extract) 5.17  0.02a
BChE inhibition (mg GALAE per g extract) 9.59  0.14a
Tyrosinase inhibition (mg KAE per g extract) 79.84  1.61a
Amylase inhibition (mmol ACAE per g extract) 0.34  0.04a
a Values expressed are means  S.D. of three parallel measurements. In e
galatamine equivalent; KAE: kojic acid equivalent; ACAE: acarbose equiva
37478 | RSC Adv., 2019, 9, 37474–37483reported anti-tyrosinase agents.38–40 High anti-tyrosinase and
anti-cholinesterase activity of A. vulgaris ethanolic extracts have
been reported.42 The EA extract (0.41 mmol ACAE per g) showed
the most eﬀective amylase inhibitor eﬀect, while the weakest
inhibitory eﬀect was found in the H2O extract. Some phenolics,
such as catechin, quercetin and luteolin-7-O-b-glucoside, could
be responsible for the observed amylase inhibitory result of EA.
In accordance with our ndings, these phenolics exhibited
signicant anti-amylase abilities.42–44 To sum up, A. vulgaris
could be suggested as valuable sources of natural enzyme
inhibitors to combat major health problems such as diabetes
and skin related disorders, as already reported ints
EtOH EA H2O
5.14  0.01a 5.21  0.05a 5.17  0.02a
9.71  0.09a 9.61  0.02a 10.19  0.16a
78.55  3.83a 77.66  2.64a 73.68  2.11b
0.32  0.03a 0.41  0.03a 0.22  0.03b
ach row diﬀerent letters mean signicant diﬀerences (p < 0.05); GALAE:
lent.
This journal is © The Royal Society of Chemistry 2019
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View Article Onlineethnobotanical notes for the Balkan region15 and as a novel
report presented in our current study – for treating the neuro-
degenerative disorders, including Alzheimer and Parkinson's
disease.Anticancer activity of A. vulgaris extracts using diﬀerent
cancer cell lines
To evaluate the impact of isolated extracts on tumor cell growth,
human breast MCF7, ovarian A2780, cervical HeLa and prostate
cancer PC-3 cell lines were used. All selected cell lines were
isolated from tumors developed in tissues regulated by
hormones and accordingly, highly sensitive to hormonal status.Fig. 1 Eﬀect of Alchemilla vulgaris extracts on diﬀerent tumor cell lines
This journal is © The Royal Society of Chemistry 2019During tumor progression, some of them like A2780, HeLa and
PC-3 lost their hormone receptors and became independent to
the treatment with hormone antagonist.45–48 This qualied
them as invasive and, in general, resistant to conventional
chemotherapeutics. Having all this in mind, it was intriguing to
assess sensitivity of hormone-dependent (MCF-7) as well as
independent cell lines (A2780, HeLa, PC-3) to diﬀerent extracts
of A. vulgaris, whose composition varied dependingon the type
of the solvent used in extraction procedure. Cells were culti-
vated with isolated extracts for 72 h when the number of viable
cells in the culture was assessed by MTT and CV tests. As pre-
sented in Table 4 and Fig. 1, H2O extract was almost ineﬃcient.
RSC Adv., 2019, 9, 37474–37483 | 37479
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View Article Onlinein tumor cell growth suppression. Three other extracts dis-
played the diﬀerent potential to decrease the number of viable
cells depending on the cell type. In general, despite diﬀerent
origin and sensitivity to hormone stimulation of tested cell lines
the strongest potential to decrease tumor cells' viability
possessed EA extract. While cervical adenocarcinoma HeLa was
almost insensitive to MeOH and EtOH, ovarian A2780 and
breast carcinoma MCF7 displayed better response to treatment
withMeOH than EtOH extract. To evaluate the selectivity toward
malignant phenotype, peritoneal exudates cells isolated from
C57BL6 mice were exposed to the same range of doses as those
used for evaluation of the cytotoxicity against malignant cells.
Diﬀerently, to tested cancer cell lines, MeOH and EtOH extracts
were not able to reduce the viability of normal cells for 50%.
Since IC50 value was not reached upon the treatment with
indicating extracts, it can be concluded that the intested range
of doses they are non-toxic for normal phenotype and therefore,
selective to malignant cells. Diﬀerently, to them, IC50 value for
EA was determined at 100 mg mL1 but, regarding to high
sensitivity of all tested lines to this extract, selectivity index
varies from 2–3, depending on the type of tumor cells. Taking
together, apart from its conrmed antioxidant and anti-
inammatory action, A. vulgaris extracts might directly impact
the growth of malignant cells. Especial importance represents
the fact the even hormone independent cell lines originating
from tumors known as highly aggressive and nonresponsive to
conventional therapy49 were sensitive to tested extracts. Despite
to ethno-botanical data showing the anticancer potential of A.
vulgaris against female reproductive tissues we might speculate
that male reproductive cancers, like in this case prostate
cancer,50 or other type of tumors can be targeted with this plant
constituents. Varying in eﬃcacy of used A. vulgaris extract
against tested cell lines might be ascribed to the diﬀerences in
content, concentration and ratio of biologically active
compounds with proven anticancer activity. Namely, it is well
recognized that both caﬀeic and gallic acid, that are present in
EA extract, possess strong anti-proliferative and cytotoxic
properties in wide range of tumor types such as those used in
this study (breast, cervical, ovarian, prostate carcinoma).51–53
These phenolic acids aﬀectedmain signaling pathways involved
in cell cycle progression and cell death. Moreover, they inter-
fered with migrative and invasive properties, epithelial/
mesenchimal transition and even angiogenesis. Very impor-
tant property of mentioned phenolic compounds is their ability
to sensitize tumor cells to conventional therapeutics or even to
aﬀect cells initially resistant to chemotherapy.53 In addition,54
genistein, protein tyrosine kinase inhibitor, and quercetin,
present in EA extract only, displayed strong anticancer potential
realized preferentially through inhibition of cell cycle progres-
sion, induction of apoptosis55 aﬀecting MAP-ERK signaling
pathway, inhibition of metastatic properties of malignant cells
etc. The anticancer properties of these molecules were even
proved in several in vivo tumor models.56 Concordantly, with
described data these isoavonesmight sensitize malignant cells
to conventional therapies. Since quercetin inhibited stem cell
proliferation,56 its presence might be highly benecial in terms
of treatment of aggressive malignant tumors. The rest of active37480 | RSC Adv., 2019, 9, 37474–37483compounds for example, catechin, are also compounds with
potential to limit tumor cell growth.57 Apart from discussed
antitumor properties, catechin modulated epigenetic events
such as DNA methylation and demethylation, as well as acety-
lation deacetylation of histones, inuence tubulin-microtu-
bule58,59 equilibrium and changed the expression of enzymes
relevant for migration and invasion of malignant cells. Plenty of
literature data conrmed that eﬃcacy of any herbal extract is
dened by the mixture and interplay of its constituents. Despite
the lack of scientic data about the anticancer features of A.
vulgaris the panel of biologically active substances inside of it
indicated its enormous potential in the eld of anticancer
therapy and needs of further evaluation.Conclusion
Alchemilla vulgaris is a generally poorly studied plant, apart
from its long and known traditional use world while. The results
obtained by the phytochemical examination and the assess-
ment of the biological activities of A. vulgaris extracts, indicated
the justication of use of the plant in traditional medicine,
mainly for woman related diseases due to hormone dependent
anticancer activity (breast and ovarian anticancer eﬀects), as
well as amylase and tyrosinase inhibitory eﬀects, which might
be related to antidiabetic and skin-related diseases, as previ-
ously reported for Lady's mantle of the Balkans region. More-
over, potential use in prevention of neuro-degenerative illnesses
was shown by inhibitory eﬀects on cholinesterases. Great bio-
logical activity of A. vulgaris. extracts is linked with its phenolic
prole, rich in catechin, quercetin and its hexoside, luteolin,
apigenin, gallic and caﬀeic acids. Our results present a rst
report on anticancer activity of hormone dependent cancer
lines, for this plant. The ethylacetate extract should be
emphasized due its exceptional antioxidant, enzyme inhibitory
and antitumor activity upon the content of the phenolic
compounds such as catechin, quercetin and phenolic acids.
Further research will be focused on mechanisms of anticancer
activity and modes of action of the key most eﬃcient plant
metabolites. Overall this Alchemilla vulgaris from Vlasina lake
(central Balkan) is a promising a valuable source of diﬀerent
bioactive compounds that could have great health benets.Conﬂicts of interest
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